ArticleAnnals of translational medicine2022

The value of the Advanced Lung Cancer Inflammation Index (ALI) in assessing the prognosis of patients with hepatocellular carcinoma treated with camrelizumab: a retrospective cohort study.

Qian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.